跳至主要内容
临床试验/IRCT20181028041483N1
IRCT20181028041483N1招募中3 期

The effect of Curcumex on fasting plasma glucose, HbA1c, Lipid profile, Insulin resistance and Inflammatory biomarkers in patients with type 2 diabetes mellitus: A randomized double blind clinical Trial.

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 80 years(—)
性别
All

入选标准

  • Baseline A1c <9%
  • Fasting blood glucose is between 200-126 mg / dl
  • Patients only use oral hypoglycemic drugs
  • Duration of diagnosis of diabetes is less than 10 years

排除标准

  • Pregnancy and lactation
  • Insulin treatment
  • Sensitization and allergy to black pepper or other ingredients in combination
  • Significant renal and hepatic failure

研究者

相似试验